The Deerborne Group Publishes Comprehensive Article on Navigating the Molecular Diagnostics Reimbursement Process

New publication identifies best-practices and highlights actionable steps organizations can take to ensure the successful navigation of the MolDx process SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — The Deerborne Group, a genomics and precision diagnostics strategy consultancy, announced…

Click here to view original post